Compare International Paper Company Common Stock (IP) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
International Paper Company Common Stock vs Kymera Therapeutics Inc. Common Stock — how do they compare? International Paper Company Common Stock trades at $32.09 (market cap $16.85B), while Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B). The key difference: International Paper Company Common Stock is the larger of the two by market cap, and International Paper Company Common Stock pays a 5.82% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Paper Company Common Stock for 0 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| IP | KYMR | |
|---|---|---|
Market Cap | $16.85B | $8.87B |
Volume | 3,482,586 | 779,107 |
Sector | Basic Materials | Health |
52-Week High | $49.19 | $127.31 |
52-Week Low | $29.38 | $55.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $25.81B | $8.26B |
Dividend Yield | 5.82% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About International Paper Company Common Stock
International Paper Company is a US producer of fiber-based packaging, pulp, and paper products, manufacturing corrugated packaging and containerboard used to ship and protect goods.
Read more on IP →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
